Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface

EcoHealth

Volumn 11, Issue 1, 2014, Pages 94-108

  Swayne, David E ^a   Spackman, Erica ^a   Pantin Jackwood, Mary ^a  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Avian influenza; disease; poultry; vaccination; vaccines; wild birds

Indexed keywords

ANAS PLATYRHYNCHOS; AVES; AVIAN INFLUENZA VIRUS;

INFLUENZA VACCINE;

ANIMAL; ANIMAL HUSBANDRY; BIRD; DISEASE ERADICATION; DISEASE OUTBREAKS; IMMUNOLOGY; INFLUENZA IN BIRDS; INFLUENZA VIRUS A H5N1; POULTRY; PROCEDURES; STATISTICS AND NUMERICAL DATA; VETERINARY;

ANIMAL HUSBANDRY; ANIMALS; BIRDS; DISEASE ERADICATION; DISEASE OUTBREAKS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY;

EID: 84902241557     PISSN: 16129202     EISSN: 16129210     Source Type: Journal    
DOI: 10.1007/s10393-013-0861-3     Document Type: Review

References (98)

1. Abbas,MA, Spackman E, Fouchier R, Smith D, Ahmed Z, Siddique N, Sarmento L, Naeem K, McKinley ET, Hameed A, Rehmani S, Swayne DE (2011) H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates. Vaccine 29:7424-7429.
2. Becker,WB (1967) Experimental infection of common terns with Tern virus: influenza virus A-Tern-South Africa-1961. Journal of Hygiene 65:61-65.
3. Bertelsen,MF, Klausen J, Holm E, Grondahl C, Jorgensen PH (2007) Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine. Vaccine 25:4345-4349.
4. Boltz,DA, Douangngeun B, Sinthasak S, Phommachanh P, Midouangchanh P, Walker D, Keating R, Khalenkov AM, Kumar M, Webster RG (2009) Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR. Archives of Virology 154:939-944.
5. Bouma,A, Muljono AT, Jatikusumah A, Nell A, Mudjiartiningsih S, Dharmayanti I, Siregar E Sawitri, Claassen I, Koch G, Stegeman JA (2008) Field trial for assessment of avian influenza vaccination effectiveness in Indonesia. Revue Scientifique et Technique Office International des Epizooties 27:633-642.
6. Bouma A, Tiensin T, Claassen I, Nielen M, van Boven M, Stegeman JA (2007) Estimation of the Critical Proportion of Chickens in a Flock to be Immunized to Prevent Major Outbreaks of HPAI H5N1. OIE/FAO/IZSVe Scientific Conference - Vaccination: a tool for the control of avian influenza, 20-22 March 2007, Verona, Italy, p 60
7. Breedlove,C, Minc JK, Tang DC, van Santen VL, van Ginkel FW, Toro H (2011) Avian influenza adenovirus-vectored in ovo vaccination: target embryo tissues and combination with Marek's disease vaccine. Avian Diseases 55:667-673.
8. Brown,JD, Stallknecht DE, Berghaus RD, Swayne DE (2009) Infectious and lethal doses of H5N1 highly pathogenic Avian influenza virus for house sparrows (Passer domesticus) and rock pigeons (Columbia livia). Journal of Veterinary Diagnostic Investigation 21:437-445.
9. Brugh,M, Beard CW, Stone HD (1979) Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines. American Journal of Veterinary Research 40:165-169.
10. Bublot,M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR (2006) Development and use of fowlpox vectored vaccines for avian influenza. Annals of the New York Academy of Sciences 1081:193-201.
11. Bublot,M, Richard-Mazet A, Chanavat-Bizzini S, Le Gros FX, Duboeuf M, Stoll A, Palfi V, Niqueux E, Guionie O, Dren N (2010) Immunogenicity of poxvirus vector avian influenza vaccines in muscovy and pekin ducks. Avian Diseases 54:232-238.
12. Cagle,C, To TL, Nguyen T, Wasilenko J, Adams SC, Cardona CJ, Spackman E, Suarez DL, Pantin-Jackwood MJ (2011) Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine. Vaccine 29:6549-6557.
13. Cattoli G, Monne I, Fusaro A, Joannis TM, Lombin LH, Aly MM, Arafa AS, Sturm-Ramirez KM, Couacy-Hymann E, Awuni JA, Batawui KB, Awoume KA, Aplogan GL, Sow A, Ngangnou AC, El Nh I, Gamatie D, Dauphin G, Domenech JM, Capua I (2009) Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates. PLoS One 4:e4842
14. CEVA (2013) Ceva develops Vectormune HVT AIV vaccine to combat avian influenza. Accessed on March 21, 2013 from http://www.ceva.com/content/download/ 20740/381139/file/Press-release-Vectormune-HVT-AIVLaunch-09042012.pdf
15. Chambers,TM, Kawaoka Y, Webster RG (1988) Protection of chickens from lethal influenza infection by vaccine-expressed hemagglutinin. Virology 167:414-421.
16. Chen,H (2009) Avian influenza vaccination: the experience in China. Revue Scientifique et Technique - Office International des Epizooties 28:267-274.
17. Costa,TP, Brown JD, Howerth EW, Stallknecht DE (2010) Effect of a prior exposure to a low pathogenic avian influenza virus in the outcome of a heterosubtypic low pathogenic avian influenza infection in mallards (Anas platyrhynchos). Avian Diseases 54:1286-1291.
18. Crawford,J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, Stone H, Perdue ML (1999) Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17:2265-2274.
19. EFSA (2007) Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) on a request from the Commission related with the vaccination against avian influenza of H5 and H7 subtypes as a preventive measure carried out in Member States in birds kept in zoos under Community approved programmes. The EFSA Journal 450. Accessed on 19 July, 2011 from doi: 10.2903/j.efsa.2007.450
20. Eggert,D, Swayne DE (2010) Single vaccination provides limited protection to ducks and geese against H5N1 high pathogenicity avian influenza virus. Avian Diseases 54:1224-1229.
21. Eggert,D, Thomas C, Spackman E, Pritchard N, Rojo F, Bublot M, Swayne DE (2010) Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry. Vaccine 28:4609-4615.
22. Ellis,TM, Barry BR, Bissett LA, Dyrting KC, Luk GSM, Tsim ST, Sturm-Ramirez K, Webster RG, Guan Y, Peiris JSM (2004) Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathology 33:492-505.
23. Ely,CR, Hall JS, Schmutz JA, Pearce JM, Terenzi J, Sedinger JS, Ip HS (2013) Evidence that Life History Characteristics of Wild Birds Influence Infection and Exposure to Influenza A Viruses. PLoS ONE 8:e57614.
24. Escorcia,M, Vazquez L, Mendez ST, Rodriguez-Ropon A, Lucio E, Nava GM (2008) Avian influenza: genetic evolution under vaccination pressure. Virology Journal 5:15.
25. Feare,CJ (2010) Role of wild birds in the spread of highly pathogenic avian influenza virus H5N1 and implications for global surveillance. Avian Diseases 54:201-212.
26. Furger,M, Hoop R, Steinmetz H, Eulenberger U, Hatt J (2008) Humoral immune response to avian influenza vaccination over a six-month period in different species of captive wild birds. Avian Diseases 52:222-228.
27. Gao,W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, Matsuoka Y, Robbins PD, Swayne DE, Donis RO, Katz JM, Barratt-Boyes SM, Gambotto A (2006) Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. Journal of Virology 80:1959-1964.
28. Ge,J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H (2007) Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. Journal of Virology 81:150-158.
29. Gilbert,M, Xiao X, Pfeiffer DU, Epprecht M, Boles S, Czarnecki C, Chaitaweesub P, Kalpravidh W, Minh PQ, Otte MJ, Martin V, Slingenbergh J (2008) Mapping H5N1 highly pathogenic avian influenza risk in Southeast Asia. Proceedings of the National Academy of Sciences of the United States of America 105:4769-4774.
30. Goot,JA, Koch G, Jong MC, Boven Mv (2003) Transmission dynamics of low- and high-pathogenicity A/Chicken/Pennsylvania/83 avian influenza viruses. Avian Diseases 47:939-941.
31. Grund C, Abdelwhab E, Arafa AS, Ziller M, Hassan MK, Aly MM, Hafez HM, Harder TC, Beer M (2011) Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 29:5567-5573
32. Guan,Y, Smith GJD, Webby R, Webster RG (2009) Molecular epidemiology of H5N1 avian influenza. Revue Scientifique et Technique Office International des Epizooties 28:39-47.
33. Hulse-Post,DJ, Sturm-Ramirez KM, Humberd J, Seiler P, Govorkova EA, Krauss S, Scholtissek C, Puthavathana P, Buranathai C, Nguyen TD, Long HT, Naipospos TSP, Chen H, Ellis TM, Guan Y, Peiris JSM, Webster RG (2005) Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proceedings of the National Academy of Sciences of the United States of America 102:10682-10687.
34. Hunt,LA, Brown DW, Robinson HL, Naeve CW, Webster RG (1988) Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. Journal of Virology 62:3014-3019.
35. Hwang,SD, Kim HS, Cho SW, Seo SH (2011) Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus. Vaccine 29:2178-2186.
36. Kalthoff,D, Giritch A, Geisler K, Bettmann U, Klimyuk V, Hehnen HR, Gleba Y, Beer M (2010) Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection. Journal of Virology 84:12002-12010.
37. Keawcharoen,J, van Riel D, van Amerongen G, Bestebroer T, Beyer WE, van Lavieren R, Osterhaus Albert DME, Fouchier Ron AM, Kuiken T (2008) Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5NI). Emerging Infectious Diseases 14:600-607.
38. Kilany WH, Abdelwhab EM, Arafa AS, Selim A, Safwat M, Nawar AA, Erfan AM, Hassan MK, Aly MM, Hafez HM (2011) Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus. Veterinary Microbiology 150:28-34
39. Kim,JK, Negovetich NJ, Forrest HL, Webster RG (2009) Ducks: the "Trojan horses" of H5N1 influenza. Influenza and other Respiratory Viruses 3:121-128.
40. Koch,G, Steensels M, Berg Tvd (2009) Vaccination of birds other than chickens and turkeys against avian influenza. Revue Scientifique et Technique - Office International des Epizooties 28:307-318.
41. Kou Z, Lei FM, Yu J, Fan ZJ, Yin ZH, Jia C, X, Xiong KJ, Sun YH, Zhang XW, Wu XM, Gao XB, Li TX (2005) New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. Journal of Virology 79:15460-15466
42. Layton,SL, Kapczynski DR, Higgins S, Higgins J, Wolfenden AD, Liljebjelke KA, Bottje WG, Swayne D, Berghman LR, Kwon YM, Hargis BM, Cole K (2009) Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge. Poultry Science 88:2244-2252.
43. Lee,CW, Senne DA, Suarez DL (2004) Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. Journal of Virology 78:8372-8381.
44. Liu,J, Chen P, Jiang Y, Wu L, Zeng X, Tian G, Ge J, Kawaoka Y, Bu Z, Chen H (2011) A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. Journal of Virology 85:10989-10998.
45. Maas R, Rosema S, Van ZD, Venema S (2011) Maternal immunity against avian influenza H5N1 in chickens: limited protection and interference with vaccine efficacy. Avian Pathology 40:87-92
46. Magalhaes,RJS, Pfeiffer DU, Otte J (2010) Evaluating the control of HPAIV H5N1 in Vietnam: virus transmission within infected flocks reported before and after vaccination. BMC Veterinary Research 6:31.
47. Middleton,D, Bingham J, Selleck P, Lowther S, Gleeson L, Lehrbach P, Robinson S, Rodenberg J, Kumar M, Andrew M (2007) Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virology 359:66-71.
48. Nettles,VF, Wood JM, Webster RG (1985) Wildlife surveillance associated with an outbreak of lethal H5N2 avian influenza in domestic poultry. Avian Diseases 29:733-741.
49. Niqueux,E, Guionie O, Schmitz A, Hars J, Jestin V (2010) Presence of serum antibodies to influenza a subtypes H5 and N1 in swans and ibises in French wetlands, irrespective of highly pathogenic H5N1 natural infection. Avian Diseases 54:502-508.
50. OIE (2007) Avian Influenza Vaccination: OIE Information Document And Verona Recommendations. Accessed March 23, 2011 from http://www.oie.int/eng/ info-ev/Other%20Files/A-Guidelines%20on%20AI%20vaccination.pdf, Paris: OIE
51. OIE (2012a) Highly Pathogenic Avian Influenza, Australia (Follow-Up Report No. 1). OIE Disease Information 25(47). Accessed 29 November, 2012 from http://www.oie.int/wahis-2/public/wahid.php/Reviewreport/Review?reportid=12568, Paris: OIE
52. OIE (2012b) Highly Pathogenic Avian Influenza, Mexico. OIE Disease Information 25(25). Accessed 2 August, 2012 from http://web.oie.int/wahis/ reports/en-imm-0000012067-20120622-132313.pdf, Paris: OIE
53. OIE (2012c) Highly Pathogenic Avian Influenza, Mexico; Follow-Up Report No. 8 (12/12/2012). OIE Disease Information 25(50). Accessed 21 March 2013 from http://www.oie.int/wahis-2/public/wahid.php/Reviewreport/Review?reportid=12466, Paris: OIE
54. Pan,Z, Zhang X, Geng S, Cheng N, Sun L, Liu B, Huang J, Jiao X (2009) Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Vaccine 27:1018-1023.
55. Pantin-Jackwood,MJ, Smith DM, Wasilenko JL, Cagle C, Shepherd E, Sarmento L, Kapczynski DR, Afonso CL (2012) Effect of age on the pathogenesis and innate immune responses in Pekin ducks infected with different H5N1 highly pathogenic avian influenza viruses. Virus Research 167:196-206.
56. Park,MS, Steel J, Garcia-Sastre A, Swayne D, Palese P (2006) Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proceedings of the National Academy of Sciences of the United States of America 103:8203-8208.
57. Pavade,G, Awada L, Hamilton K, Swayne DE (2011) Analysis of economic indicators, poultry density and performance of veterinary services for control of high pathogenicity avian influenza in poultry. Revue Scientifique et Technique - Office International des Epizooties 30:661-671.
58. Pavlova,SP, Veits J, Mettenleiter TC, Fuchs W (2009) Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Vaccine 27:5085-5090.
59. Pepin,KM, Wang J, Webb CT, Smith GJ, Poss M, Hudson PJ, Hong W, Zhu H, Riley S, Guan Y (2012) Multiannual patterns of influenza A transmission in Chinese live bird market systems. Influenza and other Respiratory Viruses 7:97-107.
60. Pfeiffer,J, Suarez DL, Sarmento L, To TL, Nguyen T, Pantin-Jackwood MJ (2010) Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam. Avian Diseases 54:262-271.
61. Philippa,J, Baas C, Beyer W, Bestebroer T, Fouchier R, Smith D, Schaftenaar W, Osterhaus A (2007) Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine 25:3800-3808.
62. Philippa,JD, Munster VJ, Bolhuis H, Bestebroer TM, Schaftenaar W, Beyer WE, Fouchier RA, Kuiken T, Osterhaus AD (2005) Highly pathogenic avian influenza (H7N7): vaccination of zoo birds and transmission to non-poultry species. Vaccine 23:5743-5750.
63. Qiu,B, Guo Y, Liu D, Zhang Q, Qiu L, Tan Z, Fan Z, He S, Tang X, Zeng S, Peng J, Wu W, Huang Y, Liu G, Lu X, Zhang C (2007) Immunological efficacy of three kinds of avian influenza inactivated vaccines in rural backyard ducks. China Poultry 29:17-19.
64. Rao,S, Kong WP, Wei C-J, Yang ZY, Nason M, Styles D, DeTolla L, Sorrell E, Song H, Wan H, Ramirez-Nieto G, Perez D, Nabel G (2008) Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice. PLoS ONE 3:e2432.
65. Rauw,F, Palya V, Van BS, Welby S, Tatar-Kis T, Gardin Y, Dorsey KM, Aly MM, Hassan MK, Soliman MA, Lambrecht B, van den Berg T (2011) Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 29:2590-2600.
66. Rohm,C, Horimoto T, Kawaoka Y, Suss J, Webster RG (1995) Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology 209:664-670.
67. Sasaki,T, Kokumai N, Ohgitani T, Sakamoto R, Takikawa N, Lin Z, Okamatsu M, Sakoda Y, Kida H (2009) Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus. Vaccine 27:5174-5177.
68. Schultz-Cherry,S, Dybing JK, Davis NL, Williamson C, Suarez DL, Johnston R, Perdue ML (2000) Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology 278:55-59.
69. Song,H, Nieto GR, Perez DR (2007) A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. Journal of Virology 81:9238-9248.
70. Steel J, Burmakina SV, Thomas C, Spackman E, Garcia-Sastre A, Swayne DE, Palese P (2008) A combination in ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 26:522-531
71. Steensels M, Bublot M, Van Borm S, De Vriese J, Lambrecht B, Richard-Mazet A, Chanavat-Bizzini S, Duboeuf M, Le Gros FX, van den BT (2009) Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 27:646-654
72. Steensels,M, Van Borm S, Lambrecht B, De Vriese J, Le Gros FX, Bublot M, van den Berg T (2007) Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Diseases 51:325-331.
73. Stone,H, Mitchell B, Brugh M (1997) In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines. Avian Diseases 41:856-863.
74. Stone,HD (1987) Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. Avian Diseases 31:483-490.
75. Sturm-Ramirez,KM, Hulse-Post DJ, Govorkova EA, Humberd J, Seiler P, Puthavathana P, Buranathai C, Nguyen TD, Chaisingh A, Long HT, Naipospos TSP, Chen H, Ellis TM, Guan Y, Peiris JSM, Webster RG (2005) Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? Journal of Virology 79:11269-11279.
76. Suarez,DL, Schultz-Cherry S (2000) The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Diseases 44:861-868.
77. Swayne,DE (2006) Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: Emphasis on Asian H5N1 high pathogenicity avian influenza. Annals of the New York Academy of Sciences 1081:174-181.
78. Swayne,DE (2008a) Avian influenza vaccines and therapies for poultry. Comparative Immunology, Microbiology and Infectious Diseases 32:351-363.
79. Swayne DE (2008b) Epidemiology of avian influenza in agricultural and other man-made systems. In: Avian Influenza, Swayne DE (editor), Ames: Wylie-Blackwell Publishing, pp 59-85
80. Swayne,DE (2012a) Impact of vaccines and vaccination on global control of avian influenza. Avian Diseases 56:818-828.
81. Swayne,DE (2012b) The role of vaccines and vaccination in high pathogenicity avian influenza control and eradication. Expert Review of Vaccines 11:877-880.
82. Swayne DE, Kapczynski DR (2008) Vaccines, vaccination and immunology for avian influenza viruses in poultry. In: Avian Influenza, DE Swayne (editor), Ames: Blackwell Publishing, pp 407-451.
83. Swayne,DE, Spackman E (2013) Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza. Developments in Biologicals (Basel) 135:79-94.
84. Swayne DE, Beck JR, Garcia M, Stone HD (1999) Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathology 28:245-255.
85. Swayne,DE, Beck JR, Kinney N (2000) Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Diseases 44:132-137.
86. Swayne,DE, Beck JR, Mickle TR (1997) Efficacy of recombinant fowl pox vaccine in protecting chickens against highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Diseases 41:910-922.
87. Swayne,DE, Eggert D, Beck JR (2012) Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine. Vaccine 30:4964-4970.
88. Swayne DE, Suarez DL, Sims LD (2013) Influenza. In: Diseases of Poultry, Swayne DE, Glisson JR, McDougald LR, Nair V, Nolan LK, Suarez Dl (editors), Ames: Wiley-Blackwell
89. Swayne,DE, Pavade G, Hamilton K, Vallat B, Miyagishima K (2011) Assessment of national strategies for control of high pathogenicity avian influenza and low pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Revue Scientifique et Technique - Office International des Epizooties 30:839-870.
90. Swayne,DE, Suarez DL, Schultz-Cherry S, Tumpey TM, King DJ, Nakaya T, Palese P, Garcia-Sastra A (2003) Recombinant Paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Diseases 47:1047-1050.
91. Tian,G, Zhang S, Li Y, Bu Z, Liu P, Zhou J, Li C, Shi J, Yu K, Chen H (2005) Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 341:153-162.
92. Toffan A, Beato MS, De Nardi R, Bertoli E, Cattoli G, Terregino C, Capua I (2007) Vaccination prevents viral colonization of muscles in experimentally infected turkeys challenged with highly pathogenic and low pathogenicity avian influenza viruses of the H7N1 subtype. OIE/FAO/IZSVe Scientific Conference - Vaccination: a tool for the control of avian influenza, 20-22 March 2007, Verona, Italy, p 64
93. Veits,J, Luschow D, Kindermann K, Werner O, Teifke JP, Mettenleiter TC, Fuchs W (2003) Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. Journal of General Virology 84:3343-3352.
94. Webster,RG, Webby RJ, Hoffmann E, Rodenberg J, Kumar M, Chu HJ, Seiler P, Krauss S, Songserm T (2006) The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 351:303-311.
95. Wilson,HM, Hall JS, Flint PL, Franson JC, Ely CR, Schmutz JA, Samuel MD (2013) High Seroprevalence of Antibodies to Avian Influenza Viruses among Wild Waterfowl in Alaska: Implications for Surveillance. PLoS ONE 8:e58308.
96. Yamamoto,Y, Nakamura K, Yamada M, Mase M (2010) Comparative pathology of chickens and domestic ducks experimentally infected with highly pathogenic avian influenza viruses (H5N1) isolated in Japan in 2007 and 2008. Japan Agricultural Research Quarterly 44:73-80.
97. Zhang,P, Tang Y, Liu X, Xue F, Qiu X, Cao Y, Gao S, Wu Y, Liu X (2005) Comparison of protective efficacy of H5N2 and H5N1 subtype inactivated oil-emulsion vaccine against H5N1 avian influenza virus (AIV) in ducks and effects of maternal antibody on immune response. China Poultry 27:8-11.
98. Zhang,W, Tu J, Zhao Z, Chen H, Jin M (2012) The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine. Virology Journal 9:97.